Literature DB >> 15509519

alpha(2)-Macroglobulin: a novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers.

Tokuo Sukata1, Satoshi Uwagawa, Keisuke Ozaki, Kayo Sumida, Kaoru Kikuchi, Masahiko Kushida, Koichi Saito, Keiichirou Morimura, Kenji Oeda, Yasuyoshi Okuno, Nobuyoshi Mikami, Shoji Fukushima.   

Abstract

We tried to identify a novel marker characteristic for rat hepatocellular preneoplastic and neoplastic lesions, undetectable by well established cytochemical markers. Glutathione S-transferase placental (GST-P)-negative hepatocellular altered foci (HAF), hepatocellular adenoma (HCA), and hepatocellular carcinoma (HCC) were generated by two initiation-promotion models with N-nitrosodiethylamine (NDEN) and peroxisome proliferators, Wy-14,643 and clofibrate. Total RNAs isolated from laser-microdissected GST-P-negative HAF (amphophilic cell foci) and adjacent normal tissues were applied to microarray analysis. As a result, five up-regulated genes were identified, and further detailed examinations of the gene demonstrating most fluctuation, ie, that for alpha(2)-macroglobulin (alpha(2)M) were performed. In reverse transcriptase-polymerase chain reaction, alpha(2)M mRNA was overexpressed not only in amphophilic GST-P-negative HAF but also in amphophilic GST-P-negative HCA and HCC. In situ hybridization showed accumulation of alpha(2)M mRNA to be evenly distributed within GST-P-negative HAF (predominantly amphophilic cell foci). Distinctive immunohistochemical staining for alpha(2)M could be consistently demonstrated in GST-P-negative HAF, HCA, and HCC induced not only by peroxisome proliferators but also N-nitrosodiethylamine alone. Thus our findings suggest that alpha(2)M is an important novel cytochemical marker to identify hepatocellular preneoplastic and neoplastic lesions, particularly amphophilic cell foci, undetectable by established cytochemical markers and is tightly linked to rat hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509519      PMCID: PMC1618685          DOI: 10.1016/s0002-9440(10)63406-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Kinetics of induction and growth of precancerous liver-cell foci, and liver tumour formation by diethylnitrosamine in the rat.

Authors:  E Scherer; P Emmelot
Journal:  Eur J Cancer       Date:  1975-10       Impact factor: 9.162

2.  Association of embryonic antigens with experimentally induced hepatic lesions in the rat.

Authors:  M Stanislawski-Birencwajg; J Uriel; P Grabar
Journal:  Cancer Res       Date:  1967-11       Impact factor: 12.701

3.  Kinetics of phenotypic maturation of remodeling of hyperplastic nodules during liver carcinogenesis.

Authors:  K Enomoto; E Farber
Journal:  Cancer Res       Date:  1982-06       Impact factor: 12.701

4.  Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats--an approach for a new medium-term bioassay system.

Authors:  N Ito; H Tsuda; M Tatematsu; T Inoue; Y Tagawa; T Aoki; S Uwagawa; M Kagawa; T Ogiso; T Masui
Journal:  Carcinogenesis       Date:  1988-03       Impact factor: 4.944

5.  Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis.

Authors:  D B Solt; A Medline; E Farber
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

6.  Phenotypic diversity as an early property of putative preneoplastic hepatocyte populations in liver carcinogenesis.

Authors:  K Ogawa; D B Solt; E Farber
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

7.  Reversibility and irreversibility of liver tumors in mice induced by the alpha isomer of 1,2,3,4,5,6-hexachlorocyclohexane.

Authors:  N Ito; M Hananouchi; S Sugihara; T Shirai; H Tsuda
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

8.  Analysis of differentially expressed genes in hepatocellular carcinoma with hepatitis C virus by suppression subtractive hybridization.

Authors:  Masayo Kotaka; George G Chen; Paul B S Lai; Wan Y Lau; Paul K S Chan; Thomas W T Leung; Authur K C Li
Journal:  Oncol Res       Date:  2002       Impact factor: 5.574

9.  The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism.

Authors:  A J Barrett; P M Starkey
Journal:  Biochem J       Date:  1973-08       Impact factor: 3.857

10.  Rat alpha-macrofetoprotein (acute-phase alpha 2-macroglobulin) during hepatocarcinogenesis.

Authors:  D Hudig; S Sell; L Newell; F F Becker
Journal:  Cancer Res       Date:  1979-09       Impact factor: 12.701

View more
  10 in total

1.  Gene expression profile related to the progression of preneoplastic nodules toward hepatocellular carcinoma in rats.

Authors:  Julio Isael Pérez-Carreón; Cristina López-García; Samia Fattel-Fazenda; Evelia Arce-Popoca; Leticia Alemán-Lazarini; Sergio Hernández-García; Véronique Le Berre; Sergueï Sokol; Jean Marie Francois; Saúl Villa-Treviño
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

2.  Anti cancerous efficacy of Ayurvedic milk extract of Semecarpus anacardium nuts on hepatocellular carcinoma in Wistar rats.

Authors:  Joice P Joseph; Sunant K Raval; Kamlesh A Sadariya; Mayur Jhala; Pranay Kumar
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-08-12

Review 3.  Molecular events in hepatic preneoplasia: a review.

Authors:  S W French
Journal:  Exp Mol Pathol       Date:  2010-01-22       Impact factor: 3.362

4.  Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers.

Authors:  John A Sandoval; Katharyn E Turner; Derek J Hoelz; Frederick J Rescorla; Robert J Hickey; Linda H Malkas
Journal:  J Surg Res       Date:  2007-08-29       Impact factor: 2.192

5.  Characteristic upregulation of glucose-regulated protein 78 in an early lesion negative for hitherto established cytochemical markers in rat hepatocarcinogenesis.

Authors:  Tokuo Sukata; Satoshi Uwagawa; Keisuke Ozaki; Kayo Sumida; Masahiko Kushida; Anna Kakehashi; Hideki Wanibuchi; Kaori Miyata; Keiko Ogata; Shoji Fukushima
Journal:  J Toxicol Pathol       Date:  2009-12-21       Impact factor: 1.628

6.  Discovering potential serological biomarker for chronic Hepatitis B Virus-related hepatocellular carcinoma in Chinese population by MAL-associated serum glycoproteomics analysis.

Authors:  Tianhua Liu; Denghe Liu; Riqiang Liu; Hucong Jiang; Guoquan Yan; Wei Li; Lu Sun; Shu Zhang; Yinkun Liu; Kun Guo
Journal:  Sci Rep       Date:  2017-01-12       Impact factor: 4.379

7.  A taxonomy of epithelial human cancer and their metastases.

Authors:  Olivier Gevaert; Anneleen Daemen; Bart De Moor; Louis Libbrecht
Journal:  BMC Med Genomics       Date:  2009-12-17       Impact factor: 3.063

8.  The role of c-Src in the invasion and metastasis of hepatocellular carcinoma cells induced by association of cell surface GRP78 with activated α2M.

Authors:  Song Zhao; Hongdan Li; Qingjun Wang; Chang Su; Guan Wang; Huijuan Song; Liang Zhao; Zhidong Luan; Rongjian Su
Journal:  BMC Cancer       Date:  2015-05-10       Impact factor: 4.430

9.  Remarkable Anticancer Activity of Teucrium polium on Hepatocellular Carcinogenic Rats.

Authors:  Ariyo Movahedi; Rusliza Basir; Asmah Rahmat; Mohammad Charaffedine; Fauziah Othman
Journal:  Evid Based Complement Alternat Med       Date:  2014-08-13       Impact factor: 2.629

10.  Integrated GlycoProteome Analyzer (I-GPA) for Automated Identification and Quantitation of Site-Specific N-Glycosylation.

Authors:  Gun Wook Park; Jin Young Kim; Heeyoun Hwang; Ju Yeon Lee; Young Hee Ahn; Hyun Kyoung Lee; Eun Sun Ji; Kwang Hoe Kim; Hoi Keun Jeong; Ki Na Yun; Yong-Sam Kim; Jeong-Heon Ko; Hyun Joo An; Jae Han Kim; Young-Ki Paik; Jong Shin Yoo
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.